Semaglutide in Psychiatry-Opportunities and Challenges
- PMID: 39167395
- DOI: 10.1001/jamapsychiatry.2024.2412
Semaglutide in Psychiatry-Opportunities and Challenges
Plain language summary
This Viewpoint discusses clinical trial results of glucagon-like peptide 1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
